Clinical Trial Update: Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intravenous indocyanine green for localizing intra-thoracic lesions, including solitary and multiple pulmonary nodules, ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Nodules
• Solitary Pulmonary Nodule

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple | Phase 1, Phase 2 | Status: COMPLETED